< Back to latest news & events

Event

Dublin IP and R&D Summit

May 2023

Event date: 29th June 2023

HGF are sponsors of the Dublin IP and R&D Summit on the 29th of June at the Dublin Convention Centre.

Covering two days, the conference will host panels and stand-alone sessions on stage; their exhibiting space will also be active, operating as a hub for professionals to network and share their experiences in the two interconnected verticals in the economy of innovation.

HGF Partner Marie Walsh will be moderating the panel and speaking on the session Get Set Go: Has the sun risen on Unitary Patents and the Unified Patent Court system? What are the challenges for Irish businesses and what strategies can be put in place to navigate forward?’. This panel session looks to cover:

  • Has the sun risen for Unitary Patents and the Unified Patent Court system?
  • What are the challenges and opportunities for Irish businesses?
  • What is the impact on Ireland for being outside the UPC System?

HGF Partner Craig Thomson will be speaking at the event on ‘Strategic Thinking on Competitor’s IP: what is to be gained and how to respond to investor questions?’.

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

T 1847/22: Procedural considerations in appeal: Re-ordering of requests and the impact on admissibility

Background This case concerned EP 3 085 344 B1, which relates to a wound pad, a self-adhesive member comprising a wound pad. The patent was opposed by two opponents. During …

Read article

Regulation of NGT plants in Europe- Polish Presidency proposes an alternative solution to the Patent ban

In the latest development on the new proposed legislation for the regulation of NGT (gene-edited) plants in the EU, the Polish Presidency have proposed an amendment which removes the proposed …

Read article

T 0295/22: EPO Technical Board of Appeal relies on “bonus effect” case law to find Amgen’s patent to orally administered apremilast lacking in inventive step

This case concerned Amgen’s European patent no. 2962690 for apremilast, a drug sold under the brand name Otezla®, licensed for the treatment of e.g., psoriasis and psoriatic arthritis.  The patent …

Read article
Event - 18th March 2025

Salzburg Seminar: Pitfalls in trade mark practice - What can be protected as a trade mark?

The registration of trade marks is a central component of trade mark protection – but which signs can actually be protected? In recent years, the national trade mark offices and …

Event details

Can the Chancellor’s so-called “Europe’s Silicon Valley” really replicate the innovative activity of its namesake?

The Chancellor of the UK, Rachel Reeves, recently unveiled plans to deliver an Oxford-Cambridge growth corridor that promises to boost the UK economy by up to £78 billion by 2035.  …

Read article

UPC’s CFI (Milan) extends deadline to file defence to infringement claim to align with parallel EPO appeal proceedings

Dainese S.p.A. v. Alpinestars S.p.A. & ors. UPC_CFI_472/2024 – Milan Local Division (Perrotti, Zana, Klein, Ashley) – 15 January 2025 The Milan Local Division granted a defendant’s request for an …

Read article